Cardiac Ablation Percutaneous Catheter
LPB is the FDA product code for Cardiac Ablation Percutaneous Catheter, a class III device type. FDA's definition for this code reads: "This product code pertains to cardiac ablation catheters indicated for general indications, treatment of supraventricular tachycardia (svt) and ventricular tachycardia (vt). This product code excludes ablation catheters indicated for treatment of atrial flutter [product code oad] and atrial fibrillation [product code...". As of , FDA records hold no 510(k) clearances under this code and 21 recalls.
Classification record
- Product code
- LPB
- Device name
- Cardiac Ablation Percutaneous Catheter
- FDA definition
- This product code pertains to cardiac ablation catheters indicated for general indications, treatment of supraventricular tachycardia (svt) and ventricular tachycardia (vt). This product code excludes ablation catheters indicated for treatment of atrial flutter [product code oad] and atrial fibrillation [product code oae].
- Device class
- Class III
- Review panel
- Unknown
- Submission type
- PMA
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 0
- Ingested recalls
- 21
Companies listing this code with FDA
Companies whose registered establishments list this code- Abbott Medical
- Abbott Medical Costa Rica Ltda.
- Amphenol Alden Products Company
- Amphenol DC Electronics
- Armm, Inc.
- ATL Technology DG,Ltd.
- Biosense Webster Inc
- Boston Scientific Corporation
- C.R. Bard Inc
- Carrio Cabling Corporation
- CEA Global Dominicana d.b.a. Nissha Medical Technologies
- CEA Medical Manufacturing, Inc.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
